Tags: Valeant | drugs | SEC | investigation

Valeant Is Under Investigation by SEC, Drugmaker Says

Monday, 29 Feb 2016 04:15 PM

Valeant Pharmaceuticals International Inc. is under investigation by the U.S. Securities and Exchange Commission in a previously undisclosed probe, the company said.

The SEC probe is separate from an existing investigation into a company purchased by Valeant last year, Salix Pharmaceuticals Ltd., said a person familiar with the matter. The Salix probe was disclosed previously. The person declined to comment on the record because the matter isn’t yet public. It’s unclear what the new probe is centered around.

“Valeant confirms that it has several ongoing investigations, including investigations by the U.S. Attorney’s Offices for Massachusetts and the Southern District of New York, the SEC, and Congress,” said Laurie Little, a Valeant spokeswoman.

Judy Burns, an SEC spokeswoman, declined to comment on the new probe.


© Copyright 2017 Bloomberg News. All rights reserved.

   
1Like our page
2Share
Companies
Valeant Pharmaceuticals International Inc. is under investigation by the U.S. Securities and Exchange Commission in a previously undisclosed probe, the company said.
Valeant, drugs, SEC, investigation
124
2016-15-29
Monday, 29 Feb 2016 04:15 PM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved